본문 바로가기
Ildong Holdings
Ildong Pharmaceutical
Ildong Bioscience
Ildong Hyaltech
Group Site
Yunovia
iLeadBMS
Idience
Aimsbioscience
Ethical Management
ENG
KOR
Company
Company
Company continuing to grow through positive changes and innovations
Greeting
About Us
Introduction
Philosophy/Vision
CI
History
Group Affiliates
Healthcare
Investing
Advertising
IT
Foundation
Compliance Program
Ethical Management
Introduction
Compliance Organization
Manufacturing Facilities
Introduction
Anseong Plant
Cheongju Plant
Consignment
NEWS
Location
Product
Product
Explore Ildong Pharmaceutical’s wide range of products.
Product Search
Finished Drugs(ETC)
Finished Drugs(OTC)
Raw Material Drugs
Health Supplements & Foods
Cosmetics
Medical Device
Others
Brand Stories
Aronamin
Biovita
Investor Information
Investor Information
Creating sustainable growth through transparent management
Share Information
Financial Information
Financial Status
IR
Disclosure Information
Notice
Financial Results
R&D
R&D
A vision-driven and value-generating global healthcare group
Strategy
Mission & Vision
R&D Strategy
Core Capabilities
Internal Organization
Ecosystem
Ildong Pharmaceutical
AIMS BioScience
Idience
iLEAD BMS
External Network
Pipeline
Global Business
Global Business
Welcomes all inquiries.
Status of Overseas Expansion
Business Model
UN SDGBI
Contact us
Ildong Pharmaceutical
Ildong Pharmaceutical
자동 롤링 정지/실행 버튼
1번 영역
2번 영역
Introduction
Ethical Management
Investor Info
Contact Us
PRODUCT
Aronamin Gold Tablets
Besivo Tablets
gQlab Postbiotics RHT
MyNi Fresh TokTok Vita C
Firstlab Probiotic Mask
자동 롤링 정지/실행 버튼
1번 영역
2번 영역
3번 영역
4번 영역
5번 영역
SEARCH
Product Search
Category Search
Finished Drugs(ETC)
Finished Drugs(OTC)
Raw Material Drugs
Health Foods & Foods
Cosmetics
Medical Device
Others
Category Search
Category Search
Finished Drugs(ETC)
Finished Drugs(OTC)
Raw Material Drugs
Health Foods & Foods
Cosmetics
Medical Device
Others
NEWS
ILDONG Pharmaceutical Participates in ‘CPhI Worldwide 2024'
2024.10.10
Ildong Pharmaceutical Participates in CPhI Worldwide 2024, Aiming to Expand Global Markets and Diversify Business Explor...
ILDONG Pharmaceutical Publishes 2024 Sustainability Management Report
2024.07.03
Showcasing ESG Achievements and Future Corporate Vision Reaffirming Commitment to Becoming a Sustainable Global Healthc...
ILDONG Pharmaceutical Group Celebrates 83rd Anniversary
2024.05.07
Reflecting on the Founders Philosophy of Contributing to Society Through Quality MedicineEmphasizing Speed and Tenacity ...
‘Aronamin’ brand Ranks No. 1 in Korea Brand Power for 11 Consecutive Years
2024.03.27
Ildong Pharmaceuticals Aronamin Ranks No. 1 in Korea Brand Power for 11 Consecutive YearsEvaluation of Brand Awareness a...
ILDONG Pharmaceuticals Secures Patents for GLP-1 Drug Candidate in China and Japan
2024.02.01
ILDONG Pharmaceuticals Secures Patents for GLP-1 Drug Candidate in China and JapanUtilizing Small-Molecule Characteristi...
이전 NEWS 보기
다음 News 보기
GLOBAL
BUSINESS
Status of Overseas
Expansion
R&D
Pipeline
BRAND STORY
Aronamin
Biovita
자동 롤링 정지/실행 버튼
1번 영역
2번 영역
LOCATION
CONTACT US